Published in PLoS Negl Trop Dis on November 06, 2014
Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut. J Immunol (2016) 0.79
Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection. Tuberculosis (Edinb) (2015) 0.78
Barriers to HIV remission research in low- and middle-income countries. J Int AIDS Soc (2017) 0.75
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest (2007) 6.56
Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol (2003) 5.97
Disease tolerance as a defense strategy. Science (2012) 5.22
Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat Rev Immunol (2008) 4.12
The immune response in tuberculosis. Annu Rev Immunol (2013) 3.91
Diversity and dialogue in immunity to helminths. Nat Rev Immunol (2011) 3.72
Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet (2006) 2.96
Immunological biomarkers of tuberculosis. Nat Rev Immunol (2011) 2.88
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects. Lancet Infect Dis (2014) 2.68
A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection. J Infect Dis (2008) 2.65
Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology (2007) 2.37
Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis (2014) 2.28
Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol (2006) 2.15
Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis (2013) 2.05
Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol (2013) 1.96
Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol (2013) 1.77
Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat Rev Immunol (2010) 1.66
Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol (2013) 1.55
Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol (2010) 1.51
Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am J Respir Crit Care Med (2014) 1.29
Matrix metalloproteinases in tuberculosis. Eur Respir J (2011) 1.28
Tuberculosis: back on the immunologists' agenda. Immunity (2006) 1.23
Inflammation markers in point-of-care testing (POCT). Anal Bioanal Chem (2008) 1.22
An alternate perspective on the roles of TIMPs and MMPs in pathology. Am J Pathol (2011) 1.21
Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS One (2011) 1.19
Coincident filarial, intestinal helminth, and mycobacterial infection: helminths fail to influence tuberculin reactivity, but BCG influences hookworm prevalence. Am J Trop Med Hyg (2006) 1.08
Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases. Immunol Rev (2014) 1.08
Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin Microbiol Infect (2005) 1.06
Impact of filarial infections on coincident intracellular pathogens: Mycobacterium tuberculosis and Plasmodium falciparum. Curr Opin HIV AIDS (2012) 1.05
A comparison of acute extensive pulmonary tuberculosis and its response to chemotherapy in Britain and Uganda. Tubercle (1956) 1.03
Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model. Immunol Res (2011) 1.00
Immunology of lymphatic filariasis. Parasite Immunol (2014) 0.99
Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol Mol Biol Rev (2013) 0.97
Where are we on worms? Curr Opin Gastroenterol (2012) 0.96
Helminthic therapy: using worms to treat immune-mediated disease. Adv Exp Med Biol (2009) 0.91
Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int J Tuberc Lung Dis (2005) 0.89
Altered circulating levels of matrix metalloproteinases and inhibitors associated with elevated type 2 cytokines in lymphatic filarial disease. PLoS Negl Trop Dis (2012) 0.86
Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis. Scand J Rheumatol (2013) 0.85
Tuberculosis: time for a new perspective? J Infect (2013) 0.81
Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses. PLoS One (2013) 0.77
Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis. Tuberculosis (Edinb) (2014) 0.86
Decreased frequencies of circulating CD4⁺ T follicular helper cells associated with diminished plasma IL-21 in active pulmonary tuberculosis. PLoS One (2014) 0.86
Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis. PLoS One (2014) 0.86
Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity. Immunology (2015) 0.85
Helminth infections coincident with active pulmonary tuberculosis inhibit mono- and multifunctional CD4+ and CD8+ T cell responses in a process dependent on IL-10. PLoS Pathog (2014) 0.85
Expansion of parasite-specific CD4+ and CD8+ T cells expressing IL-10 superfamily cytokine members and their regulation in human lymphatic filariasis. PLoS Negl Trop Dis (2014) 0.84
Parasite-antigen driven expansion of IL-5(-) and IL-5(+) Th2 human subpopulations in lymphatic filariasis and their differential dependence on IL-10 and TGFβ. PLoS Negl Trop Dis (2014) 0.84
Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1β and IL-18 in tuberculous lymphadenitis. Cytokine (2016) 0.80
Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis. PLoS One (2016) 0.80
Modulation of pro- and anti-inflammatory cytokines in active and latent tuberculosis by coexistent Strongyloides stercoralis infection. Tuberculosis (Edinb) (2015) 0.78
IL-10- and TGFβ-mediated Th9 Responses in a Human Helminth Infection. PLoS Negl Trop Dis (2016) 0.77
Type 2 diabetes mellitus coincident with pulmonary or latent tuberculosis results in modulation of adipocytokines. Cytokine (2016) 0.77
Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection. PLoS One (2017) 0.76
Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infection. PLoS Negl Trop Dis (2017) 0.75
Household Contact Screening and Yield of Tuberculosis Cases-A Clinic Based Study in Chennai, South India. PLoS One (2016) 0.75
TB lymphadenitis is associated with enhanced baseline and antigen - specific induction of Type 1 and Type 17 cytokines and reduced IL-1β and IL-18 at the site of infection. Clin Vaccine Immunol (2017) 0.75
Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors. J Infect (2016) 0.75
Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines. Tuberculosis (Edinb) (2015) 0.75
Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-β-dependent manner. Eur J Immunol (2015) 0.75
Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment. PLoS One (2017) 0.75
Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance. Antimicrob Agents Chemother (2017) 0.75